Related references
Note: Only part of the references are listed.Microhomology-mediated end joining drives complex rearrangements and overexpression of MYC and PVT1 in multiple myeloma
Aneta Mikulasova et al.
HAEMATOLOGICA (2020)
MYC dysregulation in the progression of multiple myeloma
Kristine Misund et al.
LEUKEMIA (2020)
Role of AID in the temporal pattern of acquisition of driver mutations in multiple myeloma
Francesco Maura et al.
LEUKEMIA (2020)
The evolutionary history of 2,658 cancers
Moritz Gerstung et al.
NATURE (2020)
The repertoire of mutational signatures in human cancer
Ludmil B. Alexandrov et al.
NATURE (2020)
Patterns of somatic structural variation in human cancer genomes
Yilong Li et al.
NATURE (2020)
New drugs in early development for treating multiple myeloma: all that glitters is not gold
Luca Bertamini et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2020)
Genomic Profiling of Smoldering Multiple Myeloma Identifies Patients at a High Risk of Disease Progression
Mark Bustoros et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Timing the initiation of multiple myeloma
Even H. Rustad et al.
NATURE COMMUNICATIONS (2020)
Accelerated single cell seeding in relapsed multiple myeloma
Heather J. Landau et al.
NATURE COMMUNICATIONS (2020)
Single-cell RNA sequencing reveals compromised immune microenvironment in precursor stages of multiple myeloma
Oksana Zavidij et al.
NATURE CANCER (2020)
A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis
Brian A. Walker et al.
LEUKEMIA (2019)
A genome-scale CRISPR-Cas9 screening in myeloma cells identifies regulators of immunomodulatory drug sensitivity
Jiye Liu et al.
LEUKEMIA (2019)
Subclonal evolution in disease progression from MGUS/SMM to multiple myeloma is characterised by clonal stability
Ankit K. Dutta et al.
LEUKEMIA (2019)
Deciphering the chronology of copy number alterations in Multiple Myeloma
Anil Aktas Samur et al.
BLOOD CANCER JOURNAL (2019)
Multiple myeloma immunoglobulin lambda translocations portend poor prognosis
Benjamin G. Barwick et al.
NATURE COMMUNICATIONS (2019)
A practical guide for mutational signature analysis in hematological malignancies
Francesco Maura et al.
NATURE COMMUNICATIONS (2019)
Cell of Origin and Genetic Alterations in the Pathogenesis of Multiple Myeloma
Benjamin G. Barwick et al.
FRONTIERS IN IMMUNOLOGY (2019)
Association of Immune Marker Changes With Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma
Ola Landgren et al.
JAMA ONCOLOGY (2019)
Mutational processes contributing to the development of multiple myeloma
Phuc H. Hoang et al.
BLOOD CANCER JOURNAL (2019)
The mutational footprints of cancer therapies
Oriol Pich et al.
NATURE GENETICS (2019)
Genomic landscape and chronological reconstruction of driver events in multiple myeloma
Francesco Maura et al.
NATURE COMMUNICATIONS (2019)
Early alterations in stem-like/marrow-resident T cells and innate and myeloid cells in preneoplastic gammopathy
Jithendra Kini Bailur et al.
JCI INSIGHT (2019)
Biological and prognostic impact of APOBEC-induced mutations in the spectrum of plasma cell dyscrasias and multiple myeloma cell lines
F. Maura et al.
LEUKEMIA (2018)
Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma
Brian A. Walker et al.
BLOOD (2018)
Dramatically improved survival in multiple myeloma patients in the recent decade: results from a Swedish population-based study
Sigrun Thorsteinsdottir et al.
HAEMATOLOGICA (2018)
Whole-genome sequencing of multiple myeloma reveals oncogenic pathways are targeted somatically through multiple mechanisms
Phuc H. Hoang et al.
LEUKEMIA (2018)
Analysis of the genomic landscape of multiple myeloma highlights novel prognostic markers and disease subgroups
Niccolo Bolli et al.
LEUKEMIA (2018)
The bone-marrow niche in MDS and MGUS: implications for AML and MM
Irene M. Ghobrial et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Long-Term Follow-up of Monoclonal Gammopathy of Undetermined Significance
Robert A. Kyle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Dramatically improved survival in multiple myeloma patients in the recent decade: results from a Swedish population-based study
Sigrun Thorsteinsdottir et al.
HAEMATOLOGICA (2018)
Genomic patterns of progression in smoldering multiple myeloma
Niccolo Bolli et al.
NATURE COMMUNICATIONS (2018)
Antigen-mediated regulation in monoclonal gammopathies and myeloma
Shiny Nair et al.
JCI INSIGHT (2018)
Functional Genomic Landscape of Genes with Recurrent Mutations in Multiple Myeloma
Ricardo De Matos Simoes et al.
BLOOD (2018)
Genomic complexity of multiple myeloma and its clinical implications
Salomon Manier et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
The spectrum of somatic mutations in monoclonal gammopathy of undetermined significance indicates a less complex genomic landscape than that in multiple myeloma
Aneta Mikulasova et al.
HAEMATOLOGICA (2017)
CRISPR Genome-Wide Screening Identifies Dependence on the Proteasome Subunit PSMC6 for Bortezomib Sensitivity in Multiple Myeloma
Chang-Xin Shi et al.
MOLECULAR CANCER THERAPEUTICS (2017)
HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures
Helen Davies et al.
NATURE MEDICINE (2017)
Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing
L. Rasche et al.
NATURE COMMUNICATIONS (2017)
The spectrum of somatic mutations in monoclonal gammopathy of undetermined significance indicates a less complex genomic landscape than that in multiple myeloma
Aneta Mikulasova et al.
HAEMATOLOGICA (2017)
Baseline mutational patterns and sustained MRD negativity in patients with high-risk smoldering myeloma
Sham Mailankody et al.
BLOOD ADVANCES (2017)
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
Steven H. Swerdlow et al.
BLOOD (2016)
Genomewide profiling of copy-number alteration in monoclonal gammopathy of undetermined significance
Aneta Mikulasova et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2016)
Microenvironment-dependent growth of preneoplastic and malignant plasma cells in humanized mice
Rituparna Das et al.
NATURE MEDICINE (2016)
Clonal Immunoglobulin against Lysolipids in the Origin of Myeloma
Shiny Nair et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
Antonio Palumbo et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Mutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed Myeloma
Brian A. Walker et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Non-coding recurrent mutations in chronic lymphocytic leukaemia
Xose S. Puente et al.
NATURE (2015)
Clock-like mutational processes in human somatic cells
Ludmil B. Alexandrov et al.
NATURE GENETICS (2015)
APOBEC family mutational signatures are associated with poor prognosis translocations in multiple myeloma
Brian A. Walker et al.
NATURE COMMUNICATIONS (2015)
Whole-genome sequencing reveals activation-induced cytidine deaminase signatures during indolent chronic lymphocytic leukaemia evolution
S. Kasar et al.
NATURE COMMUNICATIONS (2015)
Widespread Genetic Heterogeneity in Multiple Myeloma: Implications for Targeted Therapy
Jens G. Lohr et al.
CANCER CELL (2014)
Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence
Giulio Genovese et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes
Siddhartha Jaiswal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Heterogeneity of genomic evolution and mutational profiles in multiple myeloma
Niccolo Bolli et al.
NATURE COMMUNICATIONS (2014)
An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers
Steven A. Roberts et al.
NATURE GENETICS (2013)
Clonal competition with alternating dominance in multiple myeloma
Jonathan J. Keats et al.
BLOOD (2012)
The Life History of 21 Breast Cancers
Serena Nik-Zainal et al.
CELL (2012)
Bone Marrow Microenvironment in Multiple Myeloma Progression
S. Manier et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2012)
Evolution of the cancer genome
Lucy R. Yates et al.
NATURE REVIEWS GENETICS (2012)
The genetic architecture of multiple myeloma
Gareth J. Morgan et al.
NATURE REVIEWS CANCER (2012)
Chromothripsis identifies a rare and aggressive entity among newly diagnosed multiple myeloma patients
Florence Magrangeas et al.
BLOOD (2011)
Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study
Ola Landgren et al.
BLOOD (2009)
B-Cell Clones as Early Markers for Chronic Lymphocytic Leukemia
Ola Landgren et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Monoclonal Gammopathy of undetermined significance and smoldering multiple myeloma
Robert A. Kyle et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2007)
Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma
Robert A. Kyle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma
PL Bergsagel et al.
BLOOD (2005)
Share Paper
